Sivia Capital Partners, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 2012032
Mill Valley, CA
Position in ESPR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
25,738
-32.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sivia Capital Partners, LLC holds $3,958,512 across 4 Drug Manufacturers - Specialty & Generic names.
All Filings in ESPR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 25,738 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | — | 37,929 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | — | 37,929 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | — | 25,738 | Shares | Sole | 2025-09-24 | |
| 2024-12-31 | — | 20,000 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | — | 20,000 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | — | 20,000 | Shares | Sole | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||